There is major uncertainty regarding research funding now, and while usage trends for PacBio's systems are good, the reality is that these are expensive machines and this is not a good time to be ...

Forrest Smith, Co-Founder and CEO of Kineon, joins the show to discuss how he transformed bulky clinical machines into ... senior manager of biology at Pacific Biosciences and a scientist at ...

Molecular Biology Technologies and Protocols: High-throughput and Molecular Biology Technologies, such as PacBio, Oxford Nanopore Sequencing ... Artificial Intelligence and Machine Learning, Workflow, ...

With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers. The life sciences tools and services sector supports the research, development, and commercialization of biotechnology ...

Market forces rained on the parade of Pacific Biosciences of California, Inc. (NASDAQ:PACB) shareholders today, when the analysts downgraded their forecasts for this year. Revenue estimates were ...

MENLO PARK, CA – Pacific Biosciences of California, Inc. (NASDAQ:PACB), a leader in laboratory analytical instruments with a market capitalization of $357.59 million, has entered into a ...

MENLO PARK, CA – Pacific Biosciences of California, Inc. (NASDAQ:PACB), a leader in laboratory analytical instruments with a market capitalization of $357.59 million, has entered into a significant ...

Discover stories from this section and more in the list of contents ...

Pacific Biosciences of California has a 52 week low of $1.16 and a 52 week high of $4.10. The stock’s 50-day moving average price is $1.60 and its 200-day moving average price is $1.78.